atazanavir

(redirected from Atazanavir sulfate)
Also found in: Medical.
Related to Atazanavir sulfate: Reyataz
Translations

atazanavir

n atazanavir m
References in periodicals archive ?
Atazanavir sulfate capsules are a protease inhibitor indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection for patients 6 years and older weighing at least 15 kg.
The products include atazanavir capsule, 300 mg, ritonavir tablet, 100 mg (heat-stable) and tenofovir disoproxil fumarate and lamivudine tablet 300 mg/300 mg, or "second-line-in-a-box"; fixed-dose combination atazanavir sulfate and ritonavir tablets, 300 mg/100 mg; and fixed-dose combination abacavir sulfate, lamivudine and zidovudine tablets, 300 mg/150 mg/300 mg.
Reyataz, or atazanavir sulfate capsules, are used in combination with other medications to control HIV infection.
The NDA for cobicistat is supported by 48-week data from a pivotal Phase 3 study (Study 114) in which cobicistat met its primary objective of non-inferiority to ritonavir when both agents were administered with a background regimen of atazanavir sulfate plus Truvada([R]) (emtricitabine and tenofovir disoproxil fumarate).
has received tentative approval from the Food and Drug Administration under the President's Emergency Plan for AIDS Relief (PEPFAR) of its Abbreviated New Drug Application (ANDA) for atazanavir sulfate capsules, 150 mg and 300 mg.
The agreement transfers the manufacture and distribution of atazanavir sulfate 200 mg and 300 mg capsules in Brazil from Bristol-Myers Squibb to Farmanguinhos, a technical-scientific unit of Funda[?
According to the company, cobicistat's NDA is supported by 48-week data from a pivotal Phase 3 study, meeting its primary objective of non-inferiority to ritonavir when both agents were administered with a background regimen of atazanavir sulfate plus Truvada (emtricitabine and tenofovir disoproxil fumarate).
M2 PHARMA-December 2, 2011-FDA gives tentative nod to Mylana[euro](tm)s Atazanavir Sulfate, Ritonavir HIV/AIDS combo(C)2011 M2 COMMUNICATIONS
M2 EQUITYBITES-December 2, 2011-Mylan Inc gets tentative FDA approval for Atazanavir Sulfate and Ritonavir Tablets for HIV/AIDS plus as a second-line treatment option(C)2011 M2 COMMUNICATIONS http://www.
The agreement transfers the manufacture and distribution of atazanavir sulfate 200 mg and 300 mg capsules in Brazil from Bristol-Myers Squibb to Farmanguinhos, a technical-scientific unit of Fundacao Oswaldo Cruz (Fiocruz) and the largest official pharmaceutical laboratory of the Brazilian Ministry of Health, and to a yet to be named local maker of active pharmaceutical ingredients (API).
Under an agreement, Bristol-Myers Squibb Company will transfer the manufacture and distribution of atazanavir sulfate 200 mg & 300 mg capsules in Brazil to Farmanguinhos, a technical-scientific unit of Fundacao Oswaldo Cruz and the official pharmaceutical laboratory of the Brazilian Ministry of Health as well as to an undisclosed API local manufacturer.